Erhao Zhang

991 total citations
18 papers, 725 citations indexed

About

Erhao Zhang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Erhao Zhang has authored 18 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Erhao Zhang's work include RNA modifications and cancer (8 papers), CAR-T cell therapy research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Erhao Zhang is often cited by papers focused on RNA modifications and cancer (8 papers), CAR-T cell therapy research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Erhao Zhang collaborates with scholars based in China and Australia. Erhao Zhang's co-authors include Hanmei Xu, Mengwei Li, Weiyan Qi, Chen Liu, Chenyu Lin, Shengnan Zhang, Hanmei Xu, Peiwei Yang, Jianpeng Xue and Yihui Fan and has published in prestigious journals such as Clinical Cancer Research, Free Radical Biology and Medicine and International Journal of Cancer.

In The Last Decade

Erhao Zhang

15 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erhao Zhang China 13 410 356 182 173 114 18 725
Xiuqi Wu China 9 557 1.4× 299 0.8× 108 0.6× 355 2.1× 129 1.1× 13 816
Zhenlong Ye China 13 593 1.4× 330 0.9× 153 0.8× 342 2.0× 171 1.5× 19 909
Kesang Li China 13 364 0.9× 428 1.2× 274 1.5× 270 1.6× 83 0.7× 20 811
Lucienne Cooper United Kingdom 7 494 1.2× 407 1.1× 129 0.7× 171 1.0× 144 1.3× 8 755
Yunxin Lai China 9 504 1.2× 227 0.6× 86 0.5× 250 1.4× 175 1.5× 10 779
Anliang Xia China 12 469 1.1× 455 1.3× 260 1.4× 379 2.2× 73 0.6× 18 960
Katarzyna Urbańska United States 12 388 0.9× 346 1.0× 108 0.6× 127 0.7× 182 1.6× 16 671
Parisa Malekzadeh United States 7 651 1.6× 196 0.6× 67 0.4× 377 2.2× 150 1.3× 14 795
R. Sonali Majumdar United States 4 478 1.2× 218 0.6× 68 0.4× 196 1.1× 127 1.1× 5 620
Huiping Gao China 12 616 1.5× 248 0.7× 66 0.4× 392 2.3× 142 1.2× 22 889

Countries citing papers authored by Erhao Zhang

Since Specialization
Citations

This map shows the geographic impact of Erhao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erhao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erhao Zhang more than expected).

Fields of papers citing papers by Erhao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erhao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erhao Zhang. The network helps show where Erhao Zhang may publish in the future.

Co-authorship network of co-authors of Erhao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Erhao Zhang. A scholar is included among the top collaborators of Erhao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erhao Zhang. Erhao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Zhang, Erhao, Yichao Wang, Hongli Zhang, et al.. (2025). Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation. Free Radical Biology and Medicine. 235. 231–247. 1 indexed citations
3.
4.
5.
Li, Weihan, Chenwei Jiang, & Erhao Zhang. (2021). Advances in the phase separation-organized membraneless organelles in cells: a narrative review. Translational Cancer Research. 10(11). 4929–4946. 15 indexed citations
6.
Li, Weihan, Lei Wu, Hui Jia, et al.. (2021). The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression. Cellular & Molecular Biology Letters. 26(1). 45–45. 21 indexed citations
7.
Wu, Yingcheng, Yang Yang, Baorui Tao, et al.. (2020). Multi‐omics analysis reveals the functional transcription and potential translation of enhancers. International Journal of Cancer. 147(8). 2210–2224. 11 indexed citations
8.
Chen, Hao, Xiaoling Zhu, Rong Sun, et al.. (2020). Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. Investigational New Drugs. 38(6). 1707–1716. 19 indexed citations
9.
Yang, Peiwei, Erhao Zhang, Hui Xu, et al.. (2019). Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12. Cancer Medicine. 8(10). 4753–4765. 56 indexed citations
10.
Zhu, Xiaolin, Tingting Zhang, Ye Zhang, et al.. (2019). A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2. Cellular Signalling. 66. 109470–109470. 26 indexed citations
11.
Wu, Yingcheng, Siliang Zhang, Panpan Ma, et al.. (2019). A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2. Cell Reports. 29(11). 3435–3447.e4. 46 indexed citations
12.
Wu, Yingcheng, Hao Chen, Yuyan Chen, et al.. (2019). HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif. Aging. 11(8). 2430–2446. 14 indexed citations
13.
Zhang, Erhao, Peiwei Yang, Heming Wu, et al.. (2018). Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy. Journal of Hematology & Oncology. 11(1). 102–102. 83 indexed citations
14.
Zhang, Erhao, et al.. (2018). Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors. Molecular Cancer. 17(1). 7–7. 83 indexed citations
15.
Zhang, Erhao, Jianpeng Xue, Chenyu Lin, et al.. (2018). Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide. Journal of Hematology & Oncology. 11(1). 44–44. 41 indexed citations
16.
Li, Mengwei, Xin Li, Chenyu Lin, et al.. (2018). Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway. Cell Death and Disease. 9(2). 91–91. 36 indexed citations
17.
Lin, Chenyu, Shengnan Zhang, Ying Wang, et al.. (2017). Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis. Clinical Cancer Research. 24(2). 486–498. 116 indexed citations
18.
Zhang, Erhao & Hanmei Xu. (2017). A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy. Journal of Hematology & Oncology. 10(1). 1–1. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuqi Wu Breakdown of academic impact, for papers by Zhenlong Ye Breakdown of academic impact, for papers by Kesang Li Breakdown of academic impact, for papers by Lucienne Cooper Breakdown of academic impact, for papers by Yunxin Lai Breakdown of academic impact, for papers by Anliang Xia Breakdown of academic impact, for papers by Katarzyna Urbańska Breakdown of academic impact, for papers by Parisa Malekzadeh Breakdown of academic impact, for papers by R. Sonali Majumdar Breakdown of academic impact, for papers by Huiping Gao
Rankless by CCL
2026